A massive U.S. drug price fixing probe has hit major roadblocks

Bloomberg

30 July 2019 - Authorities have called it one of the biggest cases of corporate collusion in history, costing patients billions of dollars.

FBI agents in black vehicles pulled up at the suburban Pittsburgh headquarters of generic drug giant Mylan NV. Wearing windbreakers with block-yellow FBI logos and carrying a warrant, they headed for the fifth-floor executive offices.

The September 2016 raid was meant to surface what a multiyear Justice Department investigation hadn’t found up to that point: evidence that Mylan’s top executives played a role in what authorities have described as widespread price fixing in the generic-drug industry—potentially one of the biggest corporate collusion cases in U.S. history. Mylan, which on Monday announced a deal to be absorbed into Pfizer’s older drugs unit next year, has denied any wrongdoing.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing